Suspected adverse drug reactions of the type 2 antidiabetic drug class dipeptidyl‐peptidase IV inhibitors (DPP4i): Can polypharmacology help explain?

To interpret the relationship between the polypharmacology of dipeptidyl‐peptidase IV inhibitors (DPP4i) and their suspected adverse drug reaction (ADR) profiles using a national registry. A retrospective investigation into the suspected ADR profile of four licensed DPP4i in the United Kingdom using...

Descripción completa

Detalles Bibliográficos
Autores principales: Jones, Lauren, Jones, Alan M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9720577/
https://www.ncbi.nlm.nih.gov/pubmed/36468400
http://dx.doi.org/10.1002/prp2.1029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9720577/
https://www.ncbi.nlm.nih.gov/pubmed/36468400
http://dx.doi.org/10.1002/prp2.1029

Ejemplares similares